Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic

Detalles Bibliográficos
Autores principales: Ghajarzadeh, Mahsa, Mirmosayyeb, Omid, Barzegar, Mahdi, Nehzat, Nasim, Vaheb, Saeed, Shaygannejad, Vahid, Maghzi, Amir-Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245286/
https://www.ncbi.nlm.nih.gov/pubmed/32464586
http://dx.doi.org/10.1016/j.msard.2020.102222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245286/
https://www.ncbi.nlm.nih.gov/pubmed/32464586
http://dx.doi.org/10.1016/j.msard.2020.102222

Ejemplares similares